Related references
Note: Only part of the references are listed.Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models
Fariba Karoon Kiani et al.
LIFE SCIENCES (2022)
Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial
Hiroto Matsui Matsui et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma
Chiao-Fang Teng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Phase I studies of peptide vaccine cocktails derived from GPC3, WDRPUH and NEIL3 for advanced hepatocellular carcinoma
Masafumi Ikeda et al.
IMMUNOTHERAPY (2021)
Peptide-Based Vaccines: Current Progress and Future Challenges
Ryan J. Malonis et al.
CHEMICAL REVIEWS (2020)
Peptide vaccine as an adjuvant therapy for glypican-3-positive hepatocellular carcinoma induces peptide-specific CTLs and improves long prognosis
Masatake Taniguchi et al.
CANCER SCIENCE (2020)
One Single Site Clinical Study: To Evaluate the Safety and Efficacy of Immunotherapy With Autologous Dendritic Cells, Cytokine-Induced Killer Cells in Primary Hepatocellular Carcinoma Patients
Kaiyue Xu et al.
FRONTIERS IN ONCOLOGY (2020)
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Anliang Xia et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma
Haoyu Sun et al.
HEPATOLOGY (2019)
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
Zhenqiu Liu et al.
JOURNAL OF HEPATOLOGY (2019)
Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy
Hongyu Liu et al.
ONCOTARGET (2018)
Dendritic Cell-Based Cancer Vaccines
Patricia M. Santos et al.
JOURNAL OF IMMUNOLOGY (2018)
Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study
Yajing He et al.
JOURNAL OF CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Effect of dendritic cell based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis
Cong Chen et al.
CYTOTHERAPY (2018)
Liver-infiltrating CD11b(-)CD27(-) NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
Qiong-Fang Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein - Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma
Hidetoshi Nakagawa et al.
GASTROENTEROLOGY (2017)
Specific immunotherapy in hepatocellular cancer: A systematic review
Behnoud Baradaran Noveiry et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
Nobuhiro Tsuchiya et al.
ONCOIMMUNOLOGY (2017)
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies
Shigeru Yutani et al.
CANCER SCIENCE (2017)
TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis
Guangzhi He et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
Jeong-Hoon Lee et al.
BRITISH JOURNAL OF CANCER (2015)
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial
Yoshinari Maeda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma
Eishiro Mizukoshi et al.
CANCER LETTERS (2015)
Clinical research on dendritic cell vaccines to prevent postoperative recurrence and metastasis of liver cancer
T. Y. Sun et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Multiple courses of immunotherapy with different immune cell types for patients with hepatocellular carcinoma after microwave ablation
Ming-An Yu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Cancer vaccines
Lisa H. Butterfield
BMJ-BRITISH MEDICAL JOURNAL (2015)
Cancer vaccines
Lisa H. Butterfield
BMJ-BRITISH MEDICAL JOURNAL (2015)
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients
Shigeru Yutani et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Cheng Sun et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
Koichi Shimizu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
Mervat El Ansary et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada et al.
CLINICAL CANCER RESEARCH (2012)
Whole Cell Vaccines-Past Progress and Future Strategies
Bridget P. Keenan et al.
SEMINARS IN ONCOLOGY (2012)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
Tim F. Greten et al.
BMC CANCER (2010)
Hepatocellular carcinoma in the Asia pacific region
Man-Fung Yuen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
LH Butterfield et al.
CLINICAL CANCER RESEARCH (2006)
Tumor vaccine against recurrence of hepatocellular carcinoma
Bao-Gang Peng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells - A clinical trial
WC Lee et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Autologous fixed tumor vaccine: A formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma
BG Peng et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Share Paper
